E Cio, Inc. Exact Sciences Corp Transaction History
E Cio, Inc.
- $299 Billion
- Q1 2025
A detailed history of E Cio, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, E Cio, Inc. holds 3,345 shares of EXAS stock, worth $181,901. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,345Holding current value
$181,901% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$970 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$959 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$680 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$656 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$360 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.62B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...